Normativa su Alimenti, Farmaci e Dispositivi Medici


LMG Life Sciences 2018

Whether you’re a global biopharma leader in medical devices and drugs, a cutting-edge digital health innovator, a clinical research organization or something completely new, McDermott’s Food and Drug Administration (FDA) practice will help fuel your mission by guiding you through the complex regulatory and compliance landscape.

As the top-ranked law firm for health and a leader in life sciences, we are dedicated to our clients and passionate about the work we do together. We counsel clients on the development, manufacture, marketing and promotion, and reimbursement of drugs, biologics, devices and other products regulated by the FDA.

Show More


  • Advising the digital health business unit and regulatory team of one of the world’s leading independent biotechnology companies on FDA regulatory matters related to the development of digital health solutions, including mobile applications and software; we help the company evaluate regulatory pathways for innovative products to enter the market, manage post-market compliance issues for new products that combine biopharmaceuticals, digital technology and health IT solutions, and address related issues on the cutting edge of personalized medicine and innovative therapies
  • Advising a global genomic-based clinical laboratory services company in the development and implementation of government strategies to address FDA regulatory and Medicare reimbursement issues for their laboratory tests, including advising on compliance and fraud and abuse issues in the current environment of heightened scrutiny
  • Advising a biopharmaceutical and medical device company and its research and development arm on a range of regulatory issues related to the development and marketing of drugs and medical devices

Show More


Our cross-border, cross-practice team works collaboratively to help you clear your path to success by guiding you through the complex regulatory and compliance landscape.

Normativa su Alimenti, Farmaci e Dispositivi Medici

Insights & Events / Media

Webinar / Speaking Engagements / February 11, 2020

Cambridge, MA / McDermott Event / March 19, 2020

Pubblicazioni / January 2020

Pubblicazioni / January 2020

On the Subject / March 18, 2019

Scottsdale, Arizona / Speaking Engagements / March 25–28, 2018

On the Subject / December 10, 2018

On the Subject / June 15, 2018

Boston, Massachusetts / Speaking Engagements / June 3, 2018

Waltham, Massachusetts / Speaking Engagements / May 3, 2018

Washington, District of Columbia / Speaking Engagements / May 3-4, 2018

Boston, Massachusetts / Speaking Engagements / May 3, 2018

Las Vegas, Nevada / Speaking Engagements / April 15-18, 2018

AHLA (American Health Lawyers Association) / March 2018

Special Report / January 11, 2018

New York, New York / Speaking Engagements / December 5-6, 2017

Cambridge, Massachusetts / McDermott Event / October 4, 2017

On the Subject / September 29, 2017

Food and Drug Law Institute / August 2017

IP Update / August 2017



















... 18